Table 3 Ophthalmologic characteristics and 25(OH) concentrations in patients with senile and diabetic cataract
From: Aqueous humor and serum 25-Hydroxyvitamin D levels in patients with cataracts
| Â | N (%) | Type of cataract | P value | |
|---|---|---|---|---|
Senile, N (%) | Diabetic, N (%) | |||
Ophthalmologic examination results | ||||
 BCVA (Snellen) |  |  |  | 1.000 |
  ≤ 20/125 | 14 (10.3) | 9 (64.3) | 5 (35.7) |  |
  20/100–20/40 | 61 (44.9) | 38 (62.3) | 23 (37.7) |  |
  ≥ 20/32 | 41 (30.1) | 25 (61.0) | 16 (39.0) |  |
 IOP (mmHg) |  |  |  | 1.000 |
  ≤ 20 | 131 (96.3) | 84 (64.1) | 47 (35.9) |  |
  > 20 | 5 (3.7) | 3 (60.0) | 2 (40.0) |  |
 NC |  |  |  | 0.239 |
  0–1 | 12 (8.8) | 9 (75.0) | 3 (25.0) |  |
  2–3 | 99 (72.8) | 59 (59.6) | 40 (40.4) |  |
  4–5 | 25 (18.4) | 19 (76.0) | 6 (24.0) |  |
 NO |  |  |  | 0.135 |
  0–1 | 6 (4.4) | 5 (83.3) | 1 (16.7) |  |
  2–3 | 106 (77.9) | 63 (59.4) | 43 (40.6) |  |
  4–5 | 24 (17.6) | 19 (79.2) | 5 (20.8) |  |
 PSC |  |  |  | 0.054 |
  0–1 | 94 (69.1) | 66 (70.2) | 28 (29.8) |  |
  2–3 | 37 (27.2) | 18 (48.7) | 19 (51.4) |  |
  4–5 | 5 (3.7) | 3 (60.0) | 2 (40.0) |  |
 Central macular thickness (μm) |  |  |  | 0.534 |
  ≤ 250 | 28 (20.6) | 18 (64.3) | 10 (35.7) |  |
  250–300 | 69 (50.7) | 41 (59.4) | 28 (40.6) |  |
  > 300 | 28 (20.6) | 20 (71.4) | 8 (28.6) |  |
 Schirmer (mm) |  |  |  | 0.395 |
  ≤ 10 | 33 (24.3) | 17 (51.5) | 16 (48.5) |  |
  > 10 | 70 (51.5) | 43 (61.4) | 27 (38.6) |  |
 Spherical equivalent (D) |  |  |  | 0.186 |
  ≤ −3.0 | 34 (25) | 26 (76.5) | 8 (23.5) |  |
  -3.0–0.0 | 53 (39) | 29 (54.7) | 24 (45.3) |  |
  0.0–3.0 | 32 (23.5) | 20 (62.5) | 12 (37.5) |  |
  > 3.0 | 1 (0.7) | 1 (100.0) | 0 (0.0) |  |
 Central corneal thickness (μm) |  |  |  | 0.675 |
  ≤ 520 | 31 (22.8) | 21 (67.7) | 10 (32.3) |  |
  > 520 | 105 (77.2) | 66 (62.9) | 39 (37.1) |  |
 ECC (cells/mm2) |  |  |  | 0.468 |
  ≤ 1000 | 3 (2.2) | 3 (100.0) | 0 (0.0) |  |
  1000–2000 | 12 (8.8) | 7 (58.3) | 5 (41.7) |  |
  > 2000 | 114 (83.8) | 71 (62.3) | 43 (37.7) |  |
 Axial length (mm) |  |  |  | 0.003 |
  20–24 | 95 (69.9) | 53 (55.8) | 42 (44.2) |  |
  ≥ 24 | 41 (30.1) | 34 (82.9) | 7 (17.1) |  |
 Anterior chamber depth (mm) |  |  |  | 0.203 |
  ≤ 2 | 11 (8.1) | 5 (45.5) | 6 (54.6) |  |
  2–3 | 93 (68.4) | 58 (62.4) | 35 (37.6) |  |
  > 3 | 32 (23.5) | 24 (75.0) | 8 (25.0) |  |
 Anterior chamber volume (mm3) |  |  |  | 0.368 |
  ≤ 100 | 33 (24.3) | 19 (57.6) | 14 (42.4) |  |
  100–150 | 69 (50.7) | 43 (62.3) | 26 (37.7) |  |
  > 150 | 34 (25.0) | 25 (73.5) | 9 (26.5) |  |
25(OH) D concentrations (in quartiles, ng/mL) | ||||
 Serum |  |  |  | 0.686 |
  Q1 (≤11.78) | 35 (25.7) | 23 (65.7) | 12 (34.3) |  |
  Q2 (11.78–16.04) | 36 (26.5) | 20 (55.6) | 16 (44.4) |  |
  Q3 (16.04–25.81) | 31 (22.8) | 21 (67.7) | 10 (32.3) |  |
  Q4 (>25.81) | 34 (25.0) | 23 (67.7) | 11 (32.4) |  |
 Aqueous humor |  |  |  | 0.034 |
  Q1 (≤5.5) | 35 (25.7) | 27 (77.1) | 8 (22.9) |  |
  Q2 (5.5–10.43) | 35 (25.7) | 21 (60.0) | 14 (40.0) |  |
  Q3 (10.43–16.16) | 33 (24.3) | 24 (72.7) | 9 (27.3) |  |
  Q4 (>16.16) | 33 (24.3) | 15 (45.5) | 18 (54.6) |  |